Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
about
Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells.New spleen tyrosine kinase inhibitors: patent applications published during 2011-2013.Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2.A combined experimental and computational study of Vam3, a derivative of resveratrol, and Syk interaction.Synthesis, biological evaluation and mechanism studies of matrine derivatives as anticancer agents.
P2860
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@ast
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@en
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@nl
type
label
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@ast
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@en
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@nl
prefLabel
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@ast
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@en
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@nl
P2093
P356
P1476
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors
@en
P2093
Armando G Villaseñor
Aruna Railkar
Cheng Liao
Counde O-Yang
David M Goldstein
Eric Chiao
Fernando Padilla
Johannes C Hermann
P304
P356
10.1021/JM301720P
P407
P577
2013-02-28T00:00:00Z